Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter. -
The Financial Conduct Authority has opted to give UK borrowers the option of deferring mortgage payments for another six months, after prime minister Boris Johnson announced a second four week lockdown across the UK on Saturday, with the possibility of a further extension.
-
Investment grade corporate bond bankers are warning issuers to expect higher new issue premiums as a result of new national lockdowns, as some recent new issues have underperformed in the secondary market.
-
Fresh lockdown restrictions added to a sense of anxiety in Europe at the start of the week, with credit markets already on tenterhooks ahead of the US presidential election.
-
A €3.4bn bailout for the Dutch part of Air France-KLM was thrown into jeopardy over the weekend as the country's pilot’s union rejected the terms. Some analysts expect sweeping ramifications for the wider Dutch airline sector.
-
Brussels Airport is looking to sell US private placements, according to market sources. It is the first European airport to try its luck in the market since the coronavirus reached Europe.
